CD8A and neoplasm: IL-6 may promote the mobilization of anti-tumor CD8+ effector T cell responses, the development of APC, such as DCs and cytotoxic T cells [91,93], as well as the survival, proliferation, differentiation, and recruitment of leukocytes [94,95].